HOME >> BIOLOGY >> NEWS
Making the most of stem cells

ANAHEIM - Like many other kinds of cells used in biomedical research, human embryonic stem cells are stored and transported in a cryopreserved state, frozen to -320 degrees Fahrenheit, the temperature of their liquid nitrogen storage bath.

But when scientists thaw the cells for use in the lab, less than 1 percent awake from their frigid slumber and assume their undifferentiated state. This 'blank slate' form is characteristic of stem cells and essential for the basic science required before the promising cells are ready for the clinic. So scientists are required to place the few survivors in culture and painstakingly tend to them for weeks before new colonies are abundant enough to conduct experiments.

"Human embryonic stem cells have a very low survival rate following cryopreservation, which causes several problems," says Sean Palecek, a University of Wisconsin-Madison professor of chemical and biological engineering.

Not only does that low rate make working with human embryonic stem cells time and labor intensive, but - because so few survive freezing - it may also mean that natural selection is altering the stored cells in unknown and undesired ways, he says.

But now Palecek, along with colleagues Juan de Pablo and Lin Ji, are putting the finishing touches on a new method for preserving and storing the finicky cells. The work, presented today (March 30) at a meeting of the American Chemical Society, promises to greatly amplify the number of cells that survive their enforced hibernation, that remain undifferentiated and that are more readily available for research. What's more, with more survivors, genetic variability becomes less of an issue.

By freezing the cells attached to a gel matrix instead of suspended in solution, and adding the chemical trehalose - a disaccharide or sugar that some animals and microbes produce to protect cells and survive in dry, low-temperature conditions - the Wisconsin team was able to increase
'"/>


30-Mar-2004


Page: 1 2 3

Related biology news :

1. Making a friendlier mosquito
2. Making sense of the brains mind-boggling complexity
3. Making protein nanostructures
4. Making of mouse marks move toward mitochondrial medicine
5. Making new muscle: Researchers in Rome produce a mouse that can regenerate its tissues
6. Making sense of bacterial biodiversity
7. Making sense of the genome
8. Making a safer anthrax vaccine using spinach
9. A new twist on an age-old problem: Making knee replacements last
10. Making sense of Marfan syndrome
11. Making the most of lymphopenia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/19/2019)... ... November 19, 2019 , ... ... preparation, and Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in ... Diagenode will offer Single-Cell ATAC-Seq (scATAC-Seq) Services, featuring Bio-Rad’s Droplet Digital PCR technology, ...
(Date:11/19/2019)... ... November 19, 2019 , ... Hosted at the Las ... MJBizCon 2019 is the largest gathering of MJBiz business professionals in the ... programming to benefit every sector, there is no show quite like it. Atlantic Ultraviolet ...
(Date:11/14/2019)... POWAY, Calif. (PRWEB) , ... November 13, 2019 , ... ... successfully enrolled the first patients in an FDA approved clinical trial for stem ... anniversary of the formation of the company as a subsidiary of VetStem Biopharma. , ...
Breaking Biology News(10 mins):
(Date:1/7/2020)... ... January 06, 2020 , ... ... announced its expansion into whole-home smart lighting with two new products: the Brilliant ... the ability for homeowners and homebuilders to affordably add high-end smart lighting to ...
(Date:12/31/2019)... ... 2019 , ... At this year's SLAS conference, Visikol will present several talks ... 3D cell culture , advanced imaging and multiplex analysis . Specifically, ... steatosis , inflammation and fibrosis as well as a 2D cell culture ...
(Date:12/27/2019)... ... December 27, 2019 , ... Vici Health Sciences is ... pipeline that offers patients and healthcare providers options in the treatment of ... collaboration with doctors and managed care professionals and developed at Vici’s R&D ...
(Date:12/18/2019)... ... December 17, 2019 , ... Philadelphia ... to announce that it has hired Dr. Alia Orbin, Ph.D., J.D., an experienced ... in the preparation, filing and prosecution of patent applications related to pharmaceutical sciences, ...
Breaking Biology Technology:
Cached News: